Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Continence is a private healthcare and medical device company developing non-invasive solutions for pediatric nocturnal enuresis, commonly known as bedwetting. Its lead product, Soluu, is a wearable investigational device that combines moisture sensing, neuromodulation via transcutaneous electrical nerve stimulation, and app-enabled monitoring to help children improve nighttime bladder control. The company was founded by pediatric urologists Andrew J. Kirsch, MD, and Ubirajara Barroso, MD, PhD, and is focused on advancing evidence-based continence care. In addition to device development, Global Continence provides educational content for families and healthcare professionals, including publications and professional outreach related to bedwetting management. The business appears to be operating as an early-stage private company based in Atlanta, Georgia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Continence.